At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
EUS-FNAprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of EUS-guided FNA for Diagnosing Autoimmune Pancreatitis: a Prospective, Single-center Study
In Brief
A clinical study evaluating EUS-FNA for Autoimmune Pancreatitis. Completed, enrolled 27 participants across 1 site.
Detailed Summary
The aim is to evaluate EUS-FNA efficacy for AIP diagnosis using a 22-gauge (G) needle.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutoimmune Pancreatitis
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2013
Primary CompletionMay 2017
First PostedAug 2017
TodayJul 2026
First PostedAug 8, 2017
Enrollment StartJan 1, 2013
Primary CompletionMay 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 8.9 years ago
Interventions
EUS-FNAprocedure
Once the lesion was evaluated by EUS, the echoendoscopist would select the shortest pathway, while avoiding blood vessels, to reach the lesion. Under real-time visualization, slow-pull technique and suction technique were used to punctured each lesions. The specimens were expelled onto glass slides, and then prepared for histological and cytological examinations.